English
Korean
GBIOLOGICS

Biotechnology company

GBIOLOGICS
홈으로
PIPELINE
PIPELINE
PIPELINE
Product Indication Development Stage Remarks
Research Non-clinical Phase I Phase II Phase III
GB910(Novel) RA (Dual Action)
GB910 co-development MOA with a pharma
GB920(Novel) KRAS mutant cancer
US FDA IND application in 2021
GB930(Novel) Osteoporosis
GB100(Biosimilar) Wet aged-related macular degeneration
Local phase III clinical trials by overseas partner pharmas in 2020
GB500(IVD) SFTS
Rapid kit development completedMTA with an IVD company